BEAT News and Press, Heartbeam Inc. From 05/18/22

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today it will participate virtually in the H.C. Wainwright Global Investment Conference being held in-person and vir...

HeartBeam press release (NASDAQ:BEAT): Q1 GAAP EPS of -$0.27. Cash totaled $11.2 million as of March 31, 2022, compared to $13.2 million as of December 31, 2021. For further details see: HeartBeam GAAP EPS of -$0.27

Company Remains on Track for FDA Submission of Emergency Department (ED) Myocardial Infarction (MI) Software Product in Q2 2022 & Telehealth Solution in Q4 2022 Management to Host Webcast and Conference Call Today At 4:30 p.m. ET HeartBeam, Inc . (NASDAQ: BEA...

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will hold a conference call on Thursday May 12, 2022 at 4:30 p.m. Eastern time to discuss its results for the first quarter en...

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced that it will host a virtual roadshow webinar on Wednesday April 27, 2022 at 11:30 a.m. Eastern Time. Heart...

HeartBeam press release (NASDAQ:BEAT): FY GAAP EPS of -$1.03. The company ended 2021 with over $13.2 million in cash and cash equivalents. For further details see: HeartBeam GAAP EPS of -$1.03

Initiates Strategic Partnerships to Advance Emergency Department (ED) Myocardial Infarction (MI) Software Product & Telehealth Solution Toward FDA Submission Recent IPO Proceeds Provide Ample Cash Runway to Commercialization in FY 2022 and FY 2023 Management to Hos...

HeartBeam (NASDAQ:BEAT) has signed a professional services agreement with Triple Ring Technologies, a co-development company, to assist in the design and development of its Telehealth complete solution 3D vector Electrocardiogram collection device for remote heart attack or myocardi...

3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has...

HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will hold a conference call on Thursday, March 24, 2022 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter...